Publicaciones en colaboración con investigadores/as de University of Copenhagen (23)

2024

  1. Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

    Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892

  2. The Impact of Age and Body Composition on the Agreement between Estimated and Measured GFR in Heart Transplant Recipients

    Nephron

2023

  1. Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocol

    Basic and Clinical Pharmacology and Toxicology, Vol. 133, Núm. 3, pp. 237-253

  2. Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    The Lancet Regional Health - Europe, Vol. 33

  3. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

2022

  1. Estimating Renal Function Following Lung Transplantation

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  2. Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression

    Communications Biology, Vol. 5, Núm. 1

2021

  1. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation

    Transplant International, Vol. 34, Núm. 8, pp. 1341-1359

  2. Post-Transplant Diabetes Mellitus and Prediabetes in Renal Transplant Recipients: An Update

    Nephron, Vol. 145, Núm. 4, pp. 317-329

2020

  1. Cationic amphiphilic drugs induce elevation in lysoglycerophospholipid levels and cell death in leukemia cells

    Metabolomics, Vol. 16, Núm. 9

  2. Comprehensive Evaluation of a Quantitative Shotgun Lipidomics Platform for Mammalian Sample Analysis on a High-Resolution Mass Spectrometer

    Journal of the American Society for Mass Spectrometry, Vol. 31, Núm. 4, pp. 894-907

  3. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  4. New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

    Frontiers in Neurology, Vol. 11

2019

  1. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

  2. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 208-230

2018

  1. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415

  2. Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease

    BMC Medicine, Vol. 16, Núm. 1

2017

  1. A simple algorithm for the identification of clinical COPD phenotypes

    European Respiratory Journal, Vol. 50, Núm. 5

  2. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2015

  1. MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project

    British Journal of Cancer, Vol. 113, Núm. 2, pp. 354-363